$RMD
RESMED INC

2024 Q2 Form 10-Q Financial Statement

#000094381924000008 Filed on April 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.223B $1.197B
YoY Change 9.01% 7.17%
Cost Of Revenue $507.7M $504.2M
YoY Change 0.59% 1.01%
Gross Profit $715.5M $692.8M
YoY Change 15.9% 12.15%
Gross Profit Margin 58.5% 57.88%
Selling, General & Admin $242.2M $229.9M
YoY Change 0.62% 0.64%
% of Gross Profit 33.85% 33.19%
Research & Development $80.86M $77.07M
YoY Change 3.48% 0.83%
% of Gross Profit 11.3% 11.13%
Depreciation & Amortization $43.68M $43.47M
YoY Change -6.59% -1.99%
% of Gross Profit 6.1% 6.28%
Operating Expenses $334.3M $318.2M
YoY Change 0.95% 0.35%
Operating Profit $381.2M $374.6M
YoY Change 33.18% 24.58%
Interest Expense -$20.53M $3.333M
YoY Change 9.45% -138.18%
% of Operating Profit -5.38% 0.89%
Other Income/Expense, Net -$2.957M -$2.496M
YoY Change -4947.54% -77.9%
Pretax Income $357.7M $375.4M
YoY Change 29.24% 29.73%
Income Tax $65.50M $74.93M
% Of Pretax Income 18.31% 19.96%
Net Earnings $292.2M $300.5M
YoY Change 27.25% 29.24%
Net Earnings / Revenue 23.89% 25.1%
Basic Earnings Per Share $2.04
Diluted Earnings Per Share $1.98 $2.04
COMMON SHARES
Basic Shares Outstanding 146.9M shares 147.1M shares
Diluted Shares Outstanding 147.5M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $238.4M $237.9M
YoY Change 4.59% 4.4%
Cash & Equivalents $238.4M $237.9M
Short-Term Investments
Other Short-Term Assets $180.0M $466.7M
YoY Change 0.05% 200.13%
Inventory $822.3M $829.5M
Prepaid Expenses
Receivables $837.3M $817.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.358B $2.351B
YoY Change -0.43% 0.58%
LONG-TERM ASSETS
Property, Plant & Equipment $548.0M $686.8M
YoY Change 1.89% 29.89%
Goodwill $2.842B $2.836B
YoY Change 2.59% 1.88%
Intangibles
YoY Change
Long-Term Investments $65.46M $65.11M
YoY Change 0.15% -3.81%
Other Assets $284.0M $363.2M
YoY Change 8.21% 34.08%
Total Long-Term Assets $4.515B $4.463B
YoY Change 2.98% 1.99%
TOTAL ASSETS
Total Short-Term Assets $2.358B $2.351B
Total Long-Term Assets $4.515B $4.463B
Total Assets $6.872B $6.815B
YoY Change 1.79% 1.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $237.7M $177.4M
YoY Change 57.69% 9.6%
Accrued Expenses $377.7M $380.3M
YoY Change 3.29% 9.47%
Deferred Revenue $152.6M $150.8M
YoY Change 10.49% 6.88%
Short-Term Debt $9.900M $0.00
YoY Change -0.02% -100.0%
Long-Term Debt Due $9.900M $9.903M
YoY Change -0.02% 0.02%
Total Short-Term Liabilities $910.7M $773.0M
YoY Change 20.05% 1.49%
LONG-TERM LIABILITIES
Long-Term Debt $697.3M $997.0M
YoY Change -51.28% -36.73%
Other Long-Term Liabilities $42.26M $328.0M
YoY Change -38.01% 371.58%
Total Long-Term Liabilities $1.098B $1.325B
YoY Change -41.09% -34.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $910.7M $773.0M
Total Long-Term Liabilities $1.098B $1.325B
Total Liabilities $2.008B $2.185B
YoY Change -23.4% -21.45%
SHAREHOLDERS EQUITY
Retained Earnings $4.992B $4.770B
YoY Change 17.37% 16.68%
Common Stock $1.897B $1.848B
YoY Change 7.03% 6.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.864B $4.630B
YoY Change
Total Liabilities & Shareholders Equity $6.872B $6.815B
YoY Change 1.79% 1.5%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $292.2M $300.5M
YoY Change 27.25% 29.24%
Depreciation, Depletion And Amortization $43.68M $43.47M
YoY Change -6.59% -1.99%
Cash From Operating Activities $440.1M $402.0M
YoY Change 85.36% 42.28%
INVESTING ACTIVITIES
Capital Expenditures $26.32M $23.11M
YoY Change -32.04% -25.99%
Acquisitions
YoY Change
Other Investing Activities -$20.19M -$10.04M
YoY Change 159.16% -421.89%
Cash From Investing Activities -$46.51M -$33.15M
YoY Change -0.03% 17.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -393.3M -335.9M
YoY Change 108.54% 20.16%
NET CHANGE
Cash From Operating Activities 440.1M 402.0M
Cash From Investing Activities -46.51M -33.15M
Cash From Financing Activities -393.3M -335.9M
Net Change In Cash 322.0K 32.96M
YoY Change -86.13% -231.36%
FREE CASH FLOW
Cash From Operating Activities $440.1M $402.0M
Capital Expenditures $26.32M $23.11M
Free Cash Flow $413.8M $378.9M
YoY Change 108.25% 50.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
12157000 usd
CY2023Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
37183000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1411612000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1863272000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2184642000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2621805000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188900583 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
147064349 shares
CY2024Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
588000 usd
CY2023Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
588000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1847938000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1772083000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4769963000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4253016000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
42432422 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
41836234 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1723263000 usd
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1623256000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-265306000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-272528000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4629920000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4129903000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6814562000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3462102000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3100936000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1497350000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1340660000 usd
us-gaap Gross Profit
GrossProfit
1738275000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
674948000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
633317000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
226664000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
209498000 usd
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
35259000 usd
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
29701000 usd
us-gaap Restructuring Charges
RestructuringCharges
64228000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9157000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
317081000 usd
us-gaap Operating Expenses
OperatingExpenses
1001099000 usd
us-gaap Operating Expenses
OperatingExpenses
881673000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
374584000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
300671000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
938677000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
856602000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-11026000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-14964000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-39787000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-32436000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
440000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-183000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2716000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5037000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
13919000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
6418000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
11429000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
11506000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2496000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2564000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-537000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5773000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
837000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11293000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31611000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31740000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
375421000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
289378000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
907066000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
824862000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74929000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
56878000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
178351000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
156970000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
232500000 usd
us-gaap Net Income Loss
NetIncomeLoss
667892000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.55
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.53
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.44
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.32
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146959000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146914000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147056000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146681000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147450000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147395000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147549000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147400000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
300492000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
232500000 usd
us-gaap Net Income Loss
NetIncomeLoss
728715000 usd
us-gaap Net Income Loss
NetIncomeLoss
667892000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
77503000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-12496000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
40519000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-32699000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-134457000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
20787000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33297000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
83569000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
243538000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
240791000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
735937000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
718762000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4129903000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
983000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-225000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
17967000 usd
CY2023Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
50007000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19840000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
111796000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
208800000 usd
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4481854000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16919000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-93381000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
210478000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2022Q3 us-gaap Dividends
Dividends
64431000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3432887000 usd
CY2024Q1 us-gaap Derivative Asset Current Statement Of Financial Position Extensible Enumeration
DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q2 us-gaap Derivative Asset Current Statement Of Financial Position Extensible Enumeration
DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q2 us-gaap Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1 us-gaap Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q2 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q2 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6751708000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
318197000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
300492000 usd
us-gaap Net Income Loss
NetIncomeLoss
728715000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
CY2023Q4 us-gaap Dividends
Dividends
70678000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4679000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-314000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20442000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
213000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
50000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3360751000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2610000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-59000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5120000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-29654000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
16936000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16464000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
135960000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
224914000 usd
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2022Q4 us-gaap Dividends
Dividends
64500000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3738127000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
983000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-584000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
17832000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8291000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
232500000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2023Q1 us-gaap Dividends
Dividends
64640000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3932509000 usd
us-gaap Net Income Loss
NetIncomeLoss
728715000 usd
us-gaap Net Income Loss
NetIncomeLoss
667892000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
133192000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
118396000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
28262000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
23967000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
58792000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
51215000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2716000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5037000 usd
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
11429000 usd
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
11506000 usd
rmd Non Cash Restructuring Expenses
NonCashRestructuringExpenses
33239000 usd
rmd Non Cash Restructuring Expenses
NonCashRestructuringExpenses
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
76755000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
88452000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-163294000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
255091000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
98976000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
86607000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
96000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
31012000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
961146000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
455863000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74579000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
85223000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
13954000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
10043000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
113767000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1011225000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
9692000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
29729000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
250000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
3937000 usd
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
11533000 usd
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-18961000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-223275000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1113322000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25399000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25649000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8336000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
30297000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100007000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1293000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
316000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
105000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1070000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
535000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
260000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
211767000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
193571000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-726004000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
611465000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1848000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
178000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10019000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-45816000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227891000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273710000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237910000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227894000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
235245000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
145566000 usd
us-gaap Interest Paid Net
InterestPaidNet
39787000 usd
us-gaap Interest Paid Net
InterestPaidNet
32436000 usd
rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
38520000 usd
rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
359730000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
5401000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
148132000 usd
rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
77712000 usd
rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
803357000 usd
rmd Deferred Payment Obligations For Acquisitions
DeferredPaymentObligationsForAcquisitions
143000 usd
rmd Deferred Payment Obligations For Acquisitions
DeferredPaymentObligationsForAcquisitions
874000 usd
rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
-4372000 usd
rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
2856000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
115060000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1011225000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2024Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
24100000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
69800000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
22100000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
66200000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1196980000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1116898000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3462102000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3100936000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43474000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44356000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
133192000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
118396000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
406641000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
459126000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1845000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3956000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
420972000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
534930000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
829458000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
998012000 usd
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
126605000 usd
CY2023Q2 us-gaap Prepaid Taxes
PrepaidTaxes
114009000 usd
CY2024Q1 rmd Prepaid Inventory
PrepaidInventory
197291000 usd
CY2023Q2 rmd Prepaid Inventory
PrepaidInventory
143084000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
180767000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
179925000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
504663000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
437018000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1256561000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1205868000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
716818000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
668012000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
539743000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
537856000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
501024000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
552341000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
2043000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5037000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
2583000 usd
CY2023Q1 rmd Equity Investments
EquityInvestments
150452000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
13900000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
11400000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
2770299000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
77712000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-12018000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
2835993000 usd
CY2024Q1 rmd Marketable Equity Investments Fair Value
MarketableEquityInvestmentsFairValue
21537000 usd
CY2023Q2 rmd Marketable Equity Investments Fair Value
MarketableEquityInvestmentsFairValue
12423000 usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
77380000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
68748000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
65115000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
65366000 usd
CY2024Q1 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
164032000 usd
CY2023Q2 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
146537000 usd
CY2023Q2 rmd Equity Investments
EquityInvestments
146537000 usd
rmd Additional Equity Investments
AdditionalEquityInvestments
9692000 usd
rmd Observable Price Adjustments On Non Marketable Equity Securities
ObservablePriceAdjustmentsOnNonMarketableEquitySecurities
2315000 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-250000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-9114000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2716000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-660000 usd
CY2024Q1 rmd Equity Investments
EquityInvestments
164032000 usd
CY2022Q2 rmd Equity Investments
EquityInvestments
58375000 usd
rmd Additional Equity Investments
AdditionalEquityInvestments
86962000 usd
rmd Observable Price Adjustments On Non Marketable Equity Securities
ObservablePriceAdjustmentsOnNonMarketableEquitySecurities
12612000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
3937000 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-3937000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
3000000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
2500000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
7600000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
27621000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25889000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
15927000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
9368000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
11292000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
9561000 usd
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
315000 usd
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-144000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
31941000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25840000 usd
CY2024Q1 rmd Short Term Debt Gross
ShortTermDebtGross
10000000 usd
CY2023Q2 rmd Short Term Debt Gross
ShortTermDebtGross
10000000 usd
CY2024Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
97000 usd
CY2023Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
98000 usd
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
9903000 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
9902000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1000000000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1435000000 usd
CY2024Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2953000 usd
CY2023Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3766000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
997047000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1431234000 usd
CY2024Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1006950000 usd
CY2023Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1441136000 usd
rmd Debt To Consolidated Ebitda Ratio
DebtToConsolidatedEbitdaRatio
3.50
rmd Line Of Credit Facility Collateral Percentage Of Company
LineOfCreditFacilityCollateralPercentageOfCompany
0.10
CY2024Q1 us-gaap Senior Notes
SeniorNotes
500000000 usd
CY2023Q2 us-gaap Senior Notes
SeniorNotes
500000000 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
578065000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
403736000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
618664000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
290639000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
300492000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
232500000 usd
us-gaap Net Income Loss
NetIncomeLoss
728715000 usd
us-gaap Net Income Loss
NetIncomeLoss
667892000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146959000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146914000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147056000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146681000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
491000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
481000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
493000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
719000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147450000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147395000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147549000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147400000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.55
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.53
CY2022Q2 rmd Number Of Patents
NumberOfPatents
7 patent
CY2023Q1 rmd Number Of Patents
NumberOfPatents
3 patent
rmd Receivables Sold With Limited Recourse
ReceivablesSoldWithLimitedRecourse
148300000 usd
rmd Receivables Sold With Limited Recourse
ReceivablesSoldWithLimitedRecourse
131800000 usd
CY2024Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
35000000 usd
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
800000 usd
CY2023Q2 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
32600000 usd
CY2023 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
600000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
1810000 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
2405000 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
46394000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
70699000 usd
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000943819-24-000008-index-headers.html Edgar Link pending
0000943819-24-000008-index.html Edgar Link pending
0000943819-24-000008.txt Edgar Link pending
0000943819-24-000008-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmd-20240331.htm Edgar Link pending
rmd-20240331.xsd Edgar Link pending
rmd-20240331xex311.htm Edgar Link pending
rmd-20240331xex312.htm Edgar Link pending
rmd-20240331xex32.htm Edgar Link pending
rmd-20240331_cal.xml Edgar Link unprocessable
rmd-20240331_lab.xml Edgar Link unprocessable
rmd-20240331_pre.xml Edgar Link unprocessable
rmd-20240331_htm.xml Edgar Link completed
Show.js Edgar Link pending
rmd-20240331_def.xml Edgar Link unprocessable